Cardiotoxicity of Targeted Therapies in Non-Hematologic Cancers: Mechanisms, Risks and Monitoring
Rachida Habbal, Safia Ouarrak & Hind Dehbi · Cardiology and Angiology: An International Journal · 2025
Cardiotoxicity has emerged as an increasingly recognized concern in modern oncology, particularly with the growing use of targeted therapies such as small-molecule inhibitors and monoclonal antibodies. These agents have revolutionized cancer care by offering remarkable precision...
Open access
Research Article
10.9734/ca/2025/v14i4510